Michael R. Bishop to Tumor Lysis Syndrome
This is a "connection" page, showing publications Michael R. Bishop has written about Tumor Lysis Syndrome.
Connection Strength
0.087
-
Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002. Leukemia. 2003 Mar; 17(3):499-514.
Score: 0.057
-
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. 2013 Dec 12; 122(25):4129-39.
Score: 0.030